FR2615103B1 - PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY - Google Patents

PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY

Info

Publication number
FR2615103B1
FR2615103B1 FR8706866A FR8706866A FR2615103B1 FR 2615103 B1 FR2615103 B1 FR 2615103B1 FR 8706866 A FR8706866 A FR 8706866A FR 8706866 A FR8706866 A FR 8706866A FR 2615103 B1 FR2615103 B1 FR 2615103B1
Authority
FR
France
Prior art keywords
fractions
lymphoproliferative
leishmania
immunogenic
activities
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8706866A
Other languages
French (fr)
Other versions
FR2615103A1 (en
Inventor
Armand Berneman
Laurence Burger
Catherine Dubois
Philippe Dubois
Claude Leclerc
Jean-Marc Cavaillon
Xavier Rolland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
COMPIEGNE UNIVERSITE
Virbac SA
Institut Pasteur de Lille
Original Assignee
COMPIEGNE UNIVERSITE
Virbac SA
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by COMPIEGNE UNIVERSITE, Virbac SA, Institut Pasteur de Lille filed Critical COMPIEGNE UNIVERSITE
Priority to FR8706866A priority Critical patent/FR2615103B1/en
Publication of FR2615103A1 publication Critical patent/FR2615103A1/en
Application granted granted Critical
Publication of FR2615103B1 publication Critical patent/FR2615103B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905Protozoa
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
FR8706866A 1987-05-15 1987-05-15 PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY Expired - Lifetime FR2615103B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8706866A FR2615103B1 (en) 1987-05-15 1987-05-15 PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8706866A FR2615103B1 (en) 1987-05-15 1987-05-15 PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY

Publications (2)

Publication Number Publication Date
FR2615103A1 FR2615103A1 (en) 1988-11-18
FR2615103B1 true FR2615103B1 (en) 1990-12-07

Family

ID=9351145

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8706866A Expired - Lifetime FR2615103B1 (en) 1987-05-15 1987-05-15 PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY

Country Status (1)

Country Link
FR (1) FR2615103B1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719313B1 (en) * 1994-05-02 1996-07-19 Centre Nat Rech Scient Leishmania major protein, nucleic acid encoding this protein and their applications.
US6673351B1 (en) * 2001-03-16 2004-01-06 Astralis, Llc Compositions and methods for the treatment and clinical remission of psoriasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3581288D1 (en) * 1984-10-01 1991-02-14 Pasteur Institut ANTILEISHMANIA MONOCLONAL ANTI-BODIES, THESE ANTI-BODY ELIMINATING HYBRIDOMAS, LEISHMANIA-ANTIGENS RECOGNIZED BY THESE ANTI-BODIES, METHODS FOR THE PRODUCTION AND USE OF THESE MONOCLONAL ANTI-ANODIERS AND ANTIBODIES.

Also Published As

Publication number Publication date
FR2615103A1 (en) 1988-11-18

Similar Documents

Publication Publication Date Title
FR2624865B1 (en) PROCESS FOR PRODUCING POLYBUTENS
IT1259407B (en) LOW TEMPERATURE PROCESS FOR THE FORMATION OF CERAMIC COVERINGS
FR2634194B1 (en) PROCESS FOR THE PRODUCTION OF BOEHMITIC ALUMINS
FR2582294B1 (en) PROCESS FOR PRODUCING ALUMINA-BETA
MX165197B (en) PROCESS FOR THE PRODUCTION OF CYCLIC ESTERS
HUT45046A (en) Process for producing diaryl-alkyl-group-substituted alkylamine derivatives
PT90709A (en) PROCESS FOR TRANSFORMING PLANTS THROUGH TILLAGE POINTS
FR2593513B1 (en) FUEL PRODUCTION PROCESS
BR8807004A (en) PROCESS TO PRODUCE ETERS FROM LOWER OLEFINS
BR8706790A (en) PROCESS FOR THE PRODUCTION OF BURNED PELLETS PELLETS
BR8804166A (en) PROCESS FOR PRECIPITATION OF EMULSION FOR THE PRODUCTION OF CERAMIC POS
EP0199943A3 (en) Process for producing d-alpha-amino acids
NO174912C (en) Process for producing converted fishery products
BR8704110A (en) PROCESS FOR THE PRODUCTION OF PHALYTIC ANHYDRIDE
BR8900171A (en) PROCESS FOR THE PRODUCTION OF ZEOLITHIC CATALYST
IT9020580A0 (en) production process
FR2559490B1 (en) PROCESS FOR PRODUCING VERY PURE OLIGOGLUCOSYLFRUCTOSIDES
FR2615103B1 (en) PROCESS FOR PRODUCING LEISHMANIA FRACTIONS HAVING IMMUNOGENIC AND LYMPHOPROLIFERATIVE ACTIVITIES AND FRACTIONS OBTAINED THEREBY
BR9007035A (en) PROCESS FOR THE PRODUCTION OF GUERBET ALCOHOLS
HUT44514A (en) Process for producing 4-hydroxy-quinoline-3-carboxylic acids
FR2573771B1 (en) PROCESS FOR PRODUCING PEROXYDASE
FR2603276B1 (en) PROCESS FOR THE PRODUCTION OF GLYCOLS AND GLYCEROL BY HYDROGENOLYSIS OF ALDITOLS
FR2603471B1 (en) PROCESS FOR PRODUCING A HEADBOARD AND HEADBOARD THUS OBTAINED
FR2595714B1 (en) IMPROVED PROCESS FOR PRODUCING INTERLEUKIN-0
HUT44777A (en) Process for producing halogen-thiophene-2-carboxylic acids